| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author’s Reply to Jia et al.: “BRCA1 Expression by Immunohistochemistry and Prognosis in Ovarian Cancer: A Systematic Review and Meta‑Analysis”
|
Candido dos Reis, Francisco Jose
|
|
|
17 |
5 |
p. 607-608
|
artikel
|
| 2 |
Comment on: BRCA1 Expression by Immunohistochemistry and Prognosis in Ovarian Cancer: A Systematic Review and Meta‑Analysis
|
Jia, Daqi
|
|
|
17 |
5 |
p. 605-606
|
artikel
|
| 3 |
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm
|
O’Haire, Sophie
|
|
|
17 |
5 |
p. 539-548
|
artikel
|
| 4 |
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies
|
Santoni, Matteo
|
|
|
17 |
5 |
p. 571-581
|
artikel
|
| 5 |
Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma
|
Girgis, Suzette
|
|
|
17 |
5 |
p. 609
|
artikel
|
| 6 |
Development of a Simple and Objective Prognostication Model for Patients with Advanced Solid Malignant Tumors Treated with Immune Checkpoint Inhibitors: A Pan-Cancer Analysis
|
Sano, Asuka
|
|
|
17 |
5 |
p. 583-589
|
artikel
|
| 7 |
Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma
|
Abou-Alfa, Ghassan K.
|
|
|
17 |
5 |
p. 517-527
|
artikel
|
| 8 |
Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors
|
Nishio, Makoto
|
|
|
17 |
5 |
p. 597-604
|
artikel
|
| 9 |
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma
|
Gile, Jennifer J.
|
|
|
17 |
5 |
p. 529-538
|
artikel
|
| 10 |
Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in Cancer in Patients with Advanced Non-small Cell Lung Cancer or Melanoma: A Meta-analysis
|
Digkas, Evangelos
|
|
|
17 |
5 |
p. 507-515
|
artikel
|
| 11 |
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis
|
Rimini, Margherita
|
|
|
17 |
5 |
p. 591-596
|
artikel
|
| 12 |
Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research
|
Langouo Fontsa, Mireille
|
|
|
17 |
5 |
p. 497-505
|
artikel
|
| 13 |
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors
|
Sheng, Iris Y.
|
|
|
17 |
5 |
p. 563-569
|
artikel
|
| 14 |
Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists
|
Klink, Andrew J
|
|
|
17 |
5 |
p. 549-561
|
artikel
|
Tijdschrift beschrijving